Atlas Venture Associates IX’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-466,832
| Closed | -$4.21M | – | 7 |
|
|
2022
Q2 | $4.21M | Sell |
466,832
-450,000
| -49% | -$4.06M | 9.57% | 3 |
|
|
2022
Q1 | $6.87M | Hold |
916,832
| – | – | 6.32% | 4 |
|
|
2021
Q4 | $7.87M | Hold |
916,832
| – | – | 3.43% | 4 |
|
|
2021
Q3 | $7.71M | Hold |
916,832
| – | – | 2.56% | 6 |
|
|
2021
Q2 | $7.44M | Hold |
916,832
| – | – | 1.31% | 6 |
|
|
2021
Q1 | $8.05M | Buy |
916,832
+636
| +0.1% | +$5.58K | 1.35% | 6 |
|
|
2020
Q4 | $10.3M | Buy |
916,196
+75,812
| +9% | +$851K | 1.63% | 5 |
|
|
2020
Q3 | $7.87M | Hold |
840,384
| – | – | 8.14% | 4 |
|
|
2020
Q2 | $1.55M | Hold |
840,384
| – | – | 1.65% | 6 |
|
|
2020
Q1 | $1.38M | Hold |
840,384
| – | – | 2.91% | 6 |
|
|
2019
Q4 | $2.42M | Hold |
840,384
| – | – | 4.22% | 6 |
|
|
2019
Q3 | $4.84M | Hold |
840,384
| – | – | 7.97% | 5 |
|
|
2019
Q2 | $8.81M | Hold |
840,384
| – | – | 9.42% | 5 |
|
|
2019
Q1 | $14.8M | Hold |
840,384
| – | – | 13.86% | 5 |
|
|
2018
Q4 | $14.8M | Hold |
840,384
| – | – | 17.03% | 4 |
|
|
2018
Q3 | $34.6M | Hold |
840,384
| – | – | 18.33% | 4 |
|
|
2018
Q2 | $48.2M | Hold |
840,384
| – | – | 21.23% | 3 |
|
|
2018
Q1 | $37.3M | Buy |
+840,384
| New | +$37.3M | 28.23% | 2 |
|